Small Molecules

 

Small molecules still form the majority of all compounds used in pharmaceutical products. Often sustained release is used to reduce toxicity of these molecules. Important here is that release of the molecule is sufficiently controlled to avoid toxic levels in the blood stream.

InnoCore has several sustained release technologies that can easily be tailored to allow sustained release of small molecules. They can be used for local as well as for systemic drug delivery of small molecules for up to 6 months.

 

The top ten benefits of our sustained release technologies for small molecules:

 

Read more about our polymer platform SynBiosys® and InGell®

We use cookies for analyzing visitors behavior.